Flexion Therapeutics, Inc. (FLXN): Stock Offering News

FLXN – Prices 4.8 mln share common stock offering at $25.50/share (proceeds expected to be approximately $122.4 million and will be used to fund manufacturing and commercialization of Zilretta).

Key Facts Surrounding This News Item

  • FLXN had a POWR Rating of B (Buy) coming into today.
  • FLXN was 3.15% above its 10-Day Moving Average coming into today.
  • FLXN was 5.90% above its 20-Day Moving Average coming into today.
  • FLXN was 12.42% above its 50-Day Moving Average coming into today.
  • FLXN was 22.03% above its 100-Day Moving Average coming into today.
  • FLXN was 24.93% above its 200-Day Moving Average coming into today.
  • FLXN had returned +42.85% year-to-date leading up to today’s news, versus a 0.00% return from the benchmark S&P 500 during the same period.

More Info About Flexion Therapeutics, Inc. (FLXN)

Flexion Therapeutics focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. The company was founded in 2007 and is based in Burlington, Massachusetts. View our full FLXN ticker page with ratings, news, and more.

Try StockNews.com Premium Today!

Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

FLXN at a Glance

FLXN Current POWR Rating™
Overall POWR Rating™
FLXN Current Price $18.43 2.33%
More FLXN Ratings, Data, and News

FLXN Price Reaction

The day of this event (Oct. 11, 2017)
FLXN Closing Price$26.21 3.53%
FLXN Volume4,377,600
622.00% from avg
Leading up to this event
FLXN 1-mo return13.21%
After this event
FLXN 1-day return5.47%
FLXN 3-day return8.64%
FLXN 5-day return11.90%

FLXN Price Chart

More Flexion Therapeutics, Inc. (FLXN) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All FLXN News
Page generated in 1.4026 seconds.